EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document 62017CA0013

Case C-13/17: Judgment of the Court (Sixth Chamber) of 12 April 2018 (request for a preliminary ruling from the Conseil d’État — France) — Fédération des entreprises de la beauté v Ministre des Affaires sociales, de la Santé and des Droits des femmes, Ministre de l’Éducation nationale, de l’Enseignement supérieur et de la Recherche, Ministre de l’Économie et des Finances, formerly Ministre de l’Économie, de l’Industrie et du Numérique (Reference for a preliminary ruling — Approximation of laws — Cosmetic products — Regulation (EC) No 1223/2009 — Article 10(2) — Assessment of the safety of cosmetic products — Qualifications of the safety assessor — Recognition of equivalent training courses — Disciplines similar to pharmacy, toxicology or medicine — Member States’ discretion)

OJ C 200, 11.6.2018, p. 13–13 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

201805250141897552018/C 200/16132017CJC20020180611EN01ENINFO_JUDICIAL20180412131311

Case C-13/17: Judgment of the Court (Sixth Chamber) of 12 April 2018 (request for a preliminary ruling from the Conseil d’État — France) — Fédération des entreprises de la beauté v Ministre des Affaires sociales, de la Santé and des Droits des femmes, Ministre de l’Éducation nationale, de l’Enseignement supérieur et de la Recherche, Ministre de l’Économie et des Finances, formerly Ministre de l’Économie, de l’Industrie et du Numérique (Reference for a preliminary ruling — Approximation of laws — Cosmetic products — Regulation (EC) No 1223/2009 — Article 10(2) — Assessment of the safety of cosmetic products — Qualifications of the safety assessor — Recognition of equivalent training courses — Disciplines similar to pharmacy, toxicology or medicine — Member States’ discretion)

Top

C2002018EN1310120180412EN0016131131

Judgment of the Court (Sixth Chamber) of 12 April 2018 (request for a preliminary ruling from the Conseil d’État — France) — Fédération des entreprises de la beauté v Ministre des Affaires sociales, de la Santé and des Droits des femmes, Ministre de l’Éducation nationale, de l’Enseignement supérieur et de la Recherche, Ministre de l’Économie et des Finances, formerly Ministre de l’Économie, de l’Industrie et du Numérique

(Case C-13/17) ( 1 )

‛(Reference for a preliminary ruling — Approximation of laws — Cosmetic products — Regulation (EC) No 1223/2009 — Article 10(2) — Assessment of the safety of cosmetic products — Qualifications of the safety assessor — Recognition of equivalent training courses — Disciplines similar to pharmacy, toxicology or medicine — Member States’ discretion)’

2018/C 200/16Language of the case: French

Referring court

Conseil d’État

Parties to the main proceedings

Applicant: Fédération des entreprises de la beauté

Defendant: Ministre des Affaires sociales, de la Santé and des Droits des femmes, Ministre de l’Éducation nationale, de l’Enseignement supérieur et de la Recherche, Ministre de l’Économie et des Finances, formerly Ministre de l’Économie, de l’Industrie et du Numérique

Operative part of the judgment

1.

Article 10(2) of Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products must be interpreted as meaning that the recognition of equivalence of courses, laid down in that provision, can cover courses other than those delivered in third countries.

2.

Article 10(2) of Regulation No 1223/2009 must be interpreted as conferring on each Member State the power to determine disciplines that are ‘similar’ to pharmacy, toxicology or medicine, as well as levels of qualification satisfying the requirements of that regulation, on condition that it complies with the objectives laid down by that regulation, consisting, in particular, in guaranteeing that the person entrusted with the assessment of the safety of cosmetic products has a qualification that enables him to ensure a high level of protection of human health.


( 1 ) OJ C 95, 27.3.2017.

Top